Skip to main content

All Publications

Kevin Abrams, Miami Neuroscience InstituteFollow

A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial

Publication Date

2015

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

European Heart Journal (2015) 36(31):2070-2078

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS